Amrit Ray is on the board of Ultragenyx Pharmaceutical, Inc., Everylife Foundation for Rare Diseases and CorEvitas LLC and Chief Patient Officer at Biohaven Pharmaceuticals, Inc.

He received a doctorate and an undergraduate degree from The University of Edinburgh and an MBA from Tuck School of Business at Dartmouth.